Scientists discover promising target to block Staphylococcus infection

February 10, 2013

National Institutes of Health (NIH) scientists have identified a promising lead for developing a new type of drug to treat infection caused by Staphylococcus aureus, a bacterium that frequently resists traditional antibiotics.

The researchers discovered a system used by S. aureus to transport toxins that are thought to contribute to severe . These toxins—called phenol-soluble modulins (PSMs)—have gained much attention in recent years, but their multitude and diversity have hindered efforts to target them for drug development.

Expanding on work that first described S. aureus PSMs in 2007, scientists at the NIH's National Institute of Allergy and Infectious Diseases found that the transport system, which they call Pmt, is common to all S. aureus PSMs and critical for bacterial proliferation and disease development in a . Their experiments suggest that a drug interfering with Pmt's function could not only prevent production of the PSM toxins, but also directly lead to bacterial death.

Although their study focused on S. aureus, the scientists suspect that Pmt performs the same role in other , such as S. epidermidis, the leading cause of hospital-associated infections involving indwelling medical devices such as catheters, pacemakers and prosthetics. They plan to continue their studies to improve the understanding of how PSMs function and to learn how to interfere with the Pmt transport system to block disease.

Explore further: Factor key to severity of community-associated methicillin-resistant staph infections identified

More information: S Chatterjee et al. Essential Staphylococcus aureus toxin export system. Nature Medicine, DOI: 10.1038/nm3047 (2013).

R Wang et al. Identification of novel cytolytic peptides as key virulence determinants of community-associated MRSA. Nature Medicine, DOI: 10.1038/nm1656 (2007).

Related Stories

Evolution of virulence regulation in Staphylococcus aureus

October 9, 2008

Scientists have gained insight into the complex mechanisms that control bacterial pathogenesis and, as a result, have developed new theories about how independent mechanisms may have become intertwined during evolution. The ...

Recommended for you

Zika virus may persist in the vagina days after infection

August 25, 2016

The Zika virus reproduces in the vaginal tissue of pregnant mice several days after infection, according to a study by Yale researchers. From the genitals, the virus spreads and infects the fetal brain, impairing fetal development. ...

In sub-Saharan Africa, cancer can be an infectious disease

August 26, 2016

In 1963, Irish surgeon Denis Parson Burkitt airmailed samples of an unusual jaw tumor found in Ugandan children to his colleague, Anthony Epstein, at Middlesex Hospital in London. Epstein, an expert in chicken viruses and ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

sedona_cole_5
not rated yet Mar 11, 2013
Great to see such innovation on the war on staph and MRSA. Fortunately, yet all to little known, Microbiologist, Michelle Moore has successfully developed a very effective treatment for staph after having her own resistant case! Talk about being proactive and using her education. I only wish her work was better known, to help spare countless others of their pain, suffering, and possibly worse. Her information is at staph-infection-resources.com. Great information. Thank-you for sharing it.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.